Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
Nyboe Andersen N, Pasternak B, Andersson M, Nielsen N M, Jess T
JAMA Intern Med. 2015 Oct 5:1-2. PMID: 26437461.Abstract